Theratechnologies Stock Current Ratio
TH Stock | CAD 1.73 0.02 1.14% |
Theratechnologies fundamentals help investors to digest information that contributes to Theratechnologies' financial success or failures. It also enables traders to predict the movement of Theratechnologies Stock. The fundamental analysis module provides a way to measure Theratechnologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Theratechnologies stock.
Last Reported | Projected for Next Year | ||
Current Ratio | 1.54 | 1.46 |
Theratechnologies | Current Ratio |
Theratechnologies Company Current Ratio Analysis
Theratechnologies' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Theratechnologies Current Ratio | 1.90 X |
Most of Theratechnologies' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Theratechnologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Theratechnologies Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Theratechnologies is extremely important. It helps to project a fair market value of Theratechnologies Stock properly, considering its historical fundamentals such as Current Ratio. Since Theratechnologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Theratechnologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Theratechnologies' interrelated accounts and indicators.
Click cells to compare fundamentals
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition |
Theratechnologies Price To Sales Ratio
Price To Sales Ratio |
|
In accordance with the recently published financial statements, Theratechnologies has a Current Ratio of 1.9 times. This is 34.71% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current ratio for all Canada stocks is 12.04% higher than that of the company.
Theratechnologies Current Valuation Drivers
We derive many important indicators used in calculating different scores of Theratechnologies from analyzing Theratechnologies' financial statements. These drivers represent accounts that assess Theratechnologies' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Theratechnologies' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 713.9M | 1.2B | 830.7M | 41.9M | 37.7M | 35.8M | |
Enterprise Value | 756.5M | 1.2B | 873.5M | 66.8M | 60.1M | 57.1M |
Theratechnologies Fundamentals
Return On Equity | -11.17 | ||||
Return On Asset | -0.0455 | ||||
Profit Margin | (0.23) % | ||||
Operating Margin | (0.14) % | ||||
Current Valuation | 101.15 M | ||||
Shares Outstanding | 45.98 M | ||||
Shares Owned By Insiders | 6.28 % | ||||
Shares Owned By Institutions | 50.90 % | ||||
Number Of Shares Shorted | 15.6 K | ||||
Price To Earning | (52.28) X | ||||
Price To Book | 19.46 X | ||||
Price To Sales | 1.11 X | ||||
Revenue | 81.76 M | ||||
Gross Profit | 56.22 M | ||||
EBITDA | (2.94 M) | ||||
Net Income | (23.96 M) | ||||
Cash And Equivalents | 9.21 M | ||||
Cash Per Share | 0.35 X | ||||
Total Debt | 7.29 M | ||||
Debt To Equity | 6.46 % | ||||
Current Ratio | 1.90 X | ||||
Book Value Per Share | (0.54) X | ||||
Cash Flow From Operations | (5.68 M) | ||||
Short Ratio | 1.15 X | ||||
Earnings Per Share | (0.78) X | ||||
Price To Earnings To Growth | (199.00) X | ||||
Target Price | 6.41 | ||||
Number Of Employees | 103 | ||||
Beta | 1.81 | ||||
Market Capitalization | 80.47 M | ||||
Total Asset | 77.77 M | ||||
Retained Earnings | (408.66 M) | ||||
Working Capital | 16 M | ||||
Current Asset | 34.42 M | ||||
Current Liabilities | 16.85 M | ||||
Net Asset | 77.77 M |
About Theratechnologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Theratechnologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theratechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theratechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Theratechnologies Stock analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |